Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Twomey JD"'
Autor:
Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Publikováno v:
Biomedicines [Biomedicines] 2023 Mar 17; Vol. 11 (3). Date of Electronic Publication: 2023 Mar 17.
Autor:
Dean AQ; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Stauft CB; Laboratory of Vector-Borne Viral Diseases, Division of Viral Products, Office of Vaccine Research and Review, Food and Drug Administration, White Oak, MD 20993, USA., Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Tan J; Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA., Varani L; Institute for Research in Biomedicine, University of Switzerland, CH-1015 Lausanne, Switzerland., Wang TT; Laboratory of Vector-Borne Viral Diseases, Division of Viral Products, Office of Vaccine Research and Review, Food and Drug Administration, White Oak, MD 20993, USA., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Publikováno v:
Antibody therapeutics [Antib Ther] 2022 Dec 29; Vol. 6 (1), pp. 49-58. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).
Autor:
Dean AQ; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Bozza WP; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Luo S; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Nalli A; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: Baolin.zhang@fda.hhs.gov.
Publikováno v:
Drug discovery today [Drug Discov Today] 2021 Oct; Vol. 26 (10), pp. 2214-2220. Date of Electronic Publication: 2021 Apr 15.
Autor:
Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, USA. Julianne.Twomey@fda.hhs.gov., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, USA. Baolin.zhang@fda.hhs.gov.
Publikováno v:
The AAPS journal [AAPS J] 2021 Mar 07; Vol. 23 (2), pp. 39. Date of Electronic Publication: 2021 Mar 07.
Autor:
Dean AQ; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Luo S; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States.
Publikováno v:
MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1951427.
Autor:
Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Luo S; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Dean AQ; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Bozza WP; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Nalli A; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States. Electronic address: Baolin.zhang@fda.hhs.gov.
Publikováno v:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2020 Dec; Vol. 53, pp. 100733. Date of Electronic Publication: 2020 Oct 24.
Autor:
Mamdouhi T; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA., Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA., McSweeney KM; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA. Baolin.Zhang@fda.hhs.gov.
Publikováno v:
Cancer metastasis reviews [Cancer Metastasis Rev] 2019 Jun; Vol. 38 (1-2), pp. 297-305.
Autor:
Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. Julianne.twomey@fda.hhs.gov., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. Baolin.Zhang@fda.hhs.gov.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Jan 15; Vol. 11 (1). Date of Electronic Publication: 2019 Jan 15.
Autor:
Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Zhao L; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Luo S; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Xu Q; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Publikováno v:
Oncotarget [Oncotarget] 2018 Dec 04; Vol. 9 (95), pp. 36804-36815. Date of Electronic Publication: 2018 Dec 04 (Print Publication: 2018).
Autor:
Twomey JD; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Brahme NN; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Zhang B; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States. Electronic address: Baolin.Zhang@fda.hhs.gov.
Publikováno v:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2017 Jan; Vol. 30, pp. 48-62. Date of Electronic Publication: 2017 Feb 21.